Metastatic breast cancer: Endocrine therapy landscape reshaped

Endocrine therapy (ET) of hormone receptor (HR)-positive and human epidermal growth factor receptor 2-(HER2)-negative metastatic breast cancer (MBC) historically focused on estrogen deprivation and antagonism. The identification of several intracellular pathways promoting resistance to antiestrogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Salkeni, Mohamad Adham, Hall, Samantha June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655644/
https://www.ncbi.nlm.nih.gov/pubmed/29119080
http://dx.doi.org/10.4103/ajm.AJM_20_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655644/
https://www.ncbi.nlm.nih.gov/pubmed/29119080
http://dx.doi.org/10.4103/ajm.AJM_20_17

Ejemplares similares